Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Ark Health
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · Ark Health: Check date not recorded
vs
Verdict66/ 100
Grade C · #250Ark Health
Ark Health is a national direct-to-consumer telehealth platform with one of the widest menus in the directory — compounded semaglutide ($169/mo), tirzepatide ($249/mo) and oral semaglutide ($125/mo), plus…
Visit Ark HealthThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 66/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Ark Health still earns its place — shoppers who want broadest single-platform menu — compounded, brand and wellness adjuncts.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results60
92
Real-world results60
97Price honesty74
97
Price honesty74
96Prescriber access49
96
Prescriber access49
88Formulary choice92
88
Formulary choice92
95Cancellation fairness56
95
Cancellation fairness56
93Member support64
93
Member support64
Price, coverage & features
| Metric | CoreAge Rx | Ark Health |
|---|---|---|
| Verdict Score | 94/100 | 66/100 |
| Grade | A | C |
| Semaglutide | $99/mo | From $1,399/mo (brand Ozempic) |
| Tirzepatide | $149/mo | From $1,499/mo (brand Mounjaro) |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | Yes |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Ark Health
What we like
- Broadest menu in the directory — compounded sema/tirz injection, oral sema, brand Ozempic and Mounjaro, Sermorelin, MIC/B12
- Consistent pricing at all dosages — flat rate, no escalation as you titrate up
- Compounded oral semaglutide at $125/mo is competitive for a niche most providers don't offer
- Free expedited shipping included
- Phone support published (uncommon among DTC platforms)
The caveats
- States served not listed — can't confirm coverage in your state without contacting support
- LegitScript status not disclosed — no badge or verifiable ID
- FDA compounded-medication disclaimer not displayed
- Medical director / clinical lead not named — only generic 'certified healthcare providers'
- Pharmacy partner not named; 503A vs 503B unspecified
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Shoppers who want broadest single-platform menu — compounded, brand and wellness adjuncts.
Visit Ark Health Read the full Ark Health review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Ark Health does the reverse.
More on CoreAge Rx
More on Ark Health
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.